BOTULINUM IN MODERN UROLOGY

BOTULINUM IN MODERN UROLOGY

The advent of botulinum toxin (BT) in healthcare has revolutionized the treatment of several diseases and the aesthetic medicine. Botulinum toxin is a powerful neurotoxin with a paralytic/muscle relaxant effect. The most potent substance has been successfully used for the treatment of pathological c...

Full description

Bibliographic Details
Main Authors:	A. D. KAPRIN, O. I. APOLIKHIN, B. Y. ALEKSEEV, A. V. SIVKOV, V. V. ROMIKH, A. V. ZAKHARCHENKO, V. V. PANTELEEV, F. D. ROMIKH
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2016-12-01
Series:	Медицинский совет
Subjects:	botulinum toxin type a ndo idiopathic detrusor overactivity combined urodynamic study overactive bladder urinary incontinence
Online Access:	https://www.med-sovet.pro/jour/article/view/1416

Similar Items

The use of botulinum toxin for the treatment of overactive bladder syndrome
by: Bogdan Orasanu, et al.
Published: (2013-01-01)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
by: Mohammed A. Al-Ghazo, et al.
Published: (2011-03-01)

Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder
by: Qin-Qin Gong, et al.
Published: (2020-01-01)

Botulinum toxin A for the Treatment of Overactive Bladder
by: Po-Fan Hsieh, et al.
Published: (2016-02-01)

The application of botulinum toxin in the treatment of overactive bladder
by: Justyna Wojcik, et al.
Published: (2020-09-01)

Urodynamic Mechanisms Underlying Overactive Bladder Symptoms in Patients With Parkinson Disease
by: Gregory Vurture, et al.
Published: (2019-09-01)

Botulinum Toxin in Neurogenic Detrusor Overactivity
by: Carlos Arturo Levi D'Ancona, et al.
Published: (2012-09-01)

Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction
by: Yuan-Hong Jiang, et al.
Published: (2020-12-01)

Botulinum toxin injection: a review of injection principles and protocols
by: David E. Rapp, et al.
Published: (2007-04-01)

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
by: Aida Javan Balegh Marand, et al.
Published: (2023-05-01)

The innovative therapeutic application of botulinum toxin type A in urology patients
by: Chrysoula Belai, et al.
Published: (2016-06-01)

Efficacy of Intravesical Botulinum Toxin A Injection in the Treatment of Refractory Overactive Bladder in Children
by: Yu-Hua Fan, et al.
Published: (2023-03-01)

Low dose intradetrusor injections of onabotulinumtoxina in women with overactive bladder symptoms or the painful bladder syndrome: unfavourable balance between clinical efficacy and the need for catheterisation
by: Jan Groen, et al.
Published: (2012-01-01)

Quality of Life in Female Patients with Overactive Bladder after Botulinum Toxin Treatment
by: Agnieszka A. Licow-Kamińska, et al.
Published: (2023-12-01)

Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction
by: Hann-Chorng Kuo
Published: (2020-06-01)

NEUROMODULACIÓN PERIFÉRICA EN EL TRATAMIENTO DE LA INCONTINENCIA DE ORINA: EFECTO DE LA ESTIMULACIÓN TRANSCUTÁNEA DEL NERVIO TIBIAL POSTERIOR SOBRE LA VEJIGA HIPERACTIVA
by: Paolo Ricci A, et al.
Published: (2008-01-01)

Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis
by: Shang-Jun Wu, et al.
Published: (2019-01-01)

Trigonal-Sparing vs. Trigonal-Involved OnabotulinumtoxinA Injection for the Treatment of Overactive Bladder: A Systematic Review and Meta-Analysis
by: Yuanshan Cui, et al.
Published: (2021-10-01)

Use of Urodynamics by Gynecologists and Urologists in Brazil
by: Mucio Barata Diniz, et al.
Published: (2022-08-01)

Factors Influencing Postoperative Overactive Bladder after Adjustable Trans-Obturator Male System Implantation for Male Stress Incontinence following Prostatectomy
by: Miguel Virseda-Chamorro, et al.
Published: (2023-12-01)

Phasic or terminal detrusor overactivity in women: age, urodynamic findings and sphincter behavior relationships
by: Françoise A. Valentini, et al.
Published: (2011-12-01)

Efficacy of botulinum toxin type A 100 units versus 200 units for treatment of refractory idiopathic overactive bladder
by: Osama Abdelwahab, et al.
Published: (2015-12-01)

Application of methylene blue as an improvement of the injection technique of botulinum toxin A in the treatment of refractory idiopathic overactive bladder: prospective, single-blind (patient-blind), randomized trial
by: Michał Szczypior, et al.
Published: (2019-02-01)

The use of botulinum toxin (BoNT) in urology - review
by: Jakub Szwed, et al.
Published: (2022-08-01)

Liposome-Encapsulated Botulinum Toxin A in Treatment of Functional Bladder Disorders
by: Fan-Ching Hung, et al.
Published: (2022-12-01)

Therapeutic Approaches of Botulinum Toxin in Gynecology
by: Marius Alexandru Moga, et al.
Published: (2018-04-01)

Predictors of Nerve Stimulator Success in Patients With Overactive Bladder
by: Kristian D. Stensland, et al.
Published: (2018-09-01)

Overactive bladder in women with stress urinary incontinence
by: A. I. Neymark, et al.
Published: (2014-11-01)

Overactive bladder in women with stress urinary incontinence
by: A. I. Neymark, et al.
Published: (2014-11-01)

Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
by: Maryam Emami, et al.

Ambulatory Urodynamic Findings Change Patient Outcomes
by: Richard G. Axell, et al.
Published: (2021-11-01)

Prevalence and urodynamic characteristics of detrusor overactivity with impaired contractility in the community-dwelling elderly with non-neurogenic lower urinary tract symptoms: Is it from a single or two independent bladder dysfunctions?
by: Seong Jin Jeong, et al.
Published: (2021-07-01)

Detrusor after-contraction: a new insight
by: Françoise A. Valentini, et al.
Published: (2015-06-01)

Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?
by: Sheng-Fu Chen, et al.
Published: (2021-01-01)

Real-Time Documentation of the Effect of Onabotulinumtoxin A Detrusor Injection in OAB Patients—Preliminary Results
by: Heinrich Schulte-Baukloh, et al.
Published: (2022-12-01)

Long term safety outcomes and continuation rates of repeated Intravesical Botulinum Toxin A injections for Detrusor Overactivity: 16 year’s experience of a Tertiary Centre in the UK
by: R. Mohamed-Ahmed, et al.
Published: (2024-03-01)

Urodynamic characteristics of lower urinary tract of patients with idiopathic overactive bladder
by: Yuriy M Dekhtiar, et al.
Published: (2019-01-01)

Surgical Outcomes and Predictive Factors in Patients With Detrusor Underactivity Undergoing Bladder Outlet Obstruction Surgery
by: Ming-Syun Chuang, et al.
Published: (2024-03-01)

Experience with different botulinum toxins for the treatment of refractory neurogenic detrusor overactivity
by: Cristiano M. Gomes, et al.
Published: (2010-02-01)

Short-term outcome of onabotulinumtoxin A injection for the treatment of refractory idiopathic detrusor overactivity
by: Gamal E A. Abourjila, et al.
Published: (2020-01-01)